141 related articles for article (PubMed ID: 16505830)
1. Defining the clinical role of pharmacogenetics in antiepileptic drug therapy.
Dlugos DJ; Buono RJ; Ferraro TN
Pharmacogenomics J; 2006; 6(6):357-9. PubMed ID: 16505830
[No Abstract] [Full Text] [Related]
2. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN; Buono RJ
Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945
[TBL] [Abstract][Full Text] [Related]
3. The potential of pharmacogenetics in the treatment of epilepsy.
Depondt C
Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
[TBL] [Abstract][Full Text] [Related]
4. Response to antiepileptic drug therapy: winners and losers.
Brodie MJ
Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
[TBL] [Abstract][Full Text] [Related]
5. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
6. Update on pharmacogenetics in epilepsy: a brief review.
Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
Herranz JL
Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics and epilepsy: the road ahead.
Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.
Ferraro TN; Dlugos DJ; Buono RJ
Pharmacogenomics; 2006 Jan; 7(1):89-103. PubMed ID: 16354127
[TBL] [Abstract][Full Text] [Related]
10. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
Depondt C; Shorvon SD
Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of epilepsy: new armamentarium, new issues.
Vajda FJ
J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
Anderson GD
Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
[TBL] [Abstract][Full Text] [Related]
13. [Genetic aspects of epilepsy].
Gandelman-Marton R; Neufeld MY
Harefuah; 2008 Feb; 147(2):139-44, 182. PubMed ID: 18357672
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy pharmacogenetics.
Kasperaviciūte D; Sisodiya SM
Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
[TBL] [Abstract][Full Text] [Related]
15. ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?
Cascorbi I
Clin Pharmacol Ther; 2010 Jan; 87(1):15-8. PubMed ID: 20019695
[No Abstract] [Full Text] [Related]
16. [Epilepsy pharmacogenetics : science or fiction?].
Depondt C
Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
[TBL] [Abstract][Full Text] [Related]
17. [Impact of pharmacogenetics on the drug therapy of epilepsy].
Zang LL; Wang L; Wu Y
Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):599-602. PubMed ID: 22093423
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics in epilepsy.
Balestrini S; Sisodiya SM
Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in the treatment of epilepsy.
Clancy CE; Kass RS
Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in epilepsy: why is a simple explanation not enough?
Löscher W; Sills GJ
Epilepsia; 2007 Dec; 48(12):2370-2. PubMed ID: 18088269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
